Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Other Working Capital Changes (2017 - 2026)

Emergent BioSolutions (EBS) posted Other Working Capital Changes of $100000.0 for Q2 2026, down 80.0% on a QoQ basis from $500000.0 in Q1 2026, and up 100.51% year-over-year from $49873.4 in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Other Working Capital Changes (2017 - 2026) Analysis & Trends

Emergent BioSolutions has reported Other Working Capital Changes for 17 years, with the latest figure at $100000.0 in Q2 2026.

  • On a quarterly basis, Other Working Capital Changes rose 100.51% year-over-year to $100000.0 in Q2 2026; TTM through Jun 2026 was $18.1 million, a 146.29% increase from a year earlier, with the FY2025 full-year figure at -$11.7 million, up 93.11% from the prior year.
  • Other Working Capital Changes was $100000.0 for Q2 2026 at Emergent BioSolutions, down from $500000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $9.5 million in Q3 2023, with the low at -$19.7 million in Q1 2024.
  • Average Other Working Capital Changes over 5 years is $383333.3, with a median of $950000.0 recorded in 2023.
  • The largest YoY upside for Other Working Capital Changes was 2640.0% in 2024 against a maximum downside of 1348.12% in 2024.
  • Over 5 years, Other Working Capital Changes stood at -$25.0 million in 2022, then declined by 20.0% to -$30.0 million in 2023, then rose by 21.33% to -$23.6 million in 2024, then soared by 165.25% to $15.4 million in 2025, then plunged by 99.35% to $100000.0 in 2026.
  • The last three Other Working Capital Changes figures came in at $100000.0 (Q2 2026), $500000.0 (Q1 2026), and $15.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn
9 Revolution Medicines 41.30 Bn 41.30 Bn -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.30 Mn
Jun 30, 2026 3.30 Mn
Mar 31, 2026 3.20 Mn
Mar 31, 2026 3.20 Mn
Dec 31, 2025 4.10 Mn
Dec 31, 2025 4.10 Mn
Sep 30, 2025 1.20 Mn
Sep 30, 2025 1.20 Mn
Jun 30, 2025 200,000.00
Jun 30, 2025 200,000.00
Mar 31, 2025 -300,000.00
Mar 31, 2025 -300,000.00
Dec 31, 2024 -1.50 Mn
Dec 31, 2024 -1.50 Mn
Sep 30, 2024 700,000.00
Sep 30, 2024 700,000.00
Jun 30, 2024 200,000.00
Jun 30, 2024 200,000.00
Mar 31, 2024 -19.70 Mn
Mar 31, 2024 -19.70 Mn
API Access

Emergent BioSolutions Other Working Capital Changes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=EBS&period=max&api_key=YOUR_API_KEY